CVRx Inc (CVRX NASDAQ) stock market data APIs
$9.6744
0.4(4.1%)
as of November 7, 2025
Try our APIs with
free plan!
CVRx Inc Financial Data Overview
Price chart is built with
Anychart
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Prev. Close
9.6744
Open
10.0715
High
10.2893
Low
8.9198
52 wk Range
4.2993-18.55
Market Cap
255 M
Shares Outstanding
26 073 K
Revenue
55 969 K
EPS
-0.49
Beta
1.248
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with CVRx Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CVRx Inc data using free add-ons & libraries
Get CVRx Inc Fundamental Data
CVRx Inc Fundamental data includes:
- Net Revenue: 55 969 K
- EBITDA: -49 598 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-04
- EPS/Forecast: -0.5
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CVRx Inc News
New
Medtech Stocks Reignite After Hours: RxSight, Penumbra, Evolus Lead The Charge
(RTTNews) - Several healthcare and medtech stocks staged notable rebounds in after-hours trading Wednesday, with gains driven by updated guidance, margin improvements, and signs of operational resilie...
CVRx anticipates mid-teens growth in 2026 as sales force productivity and reimbursement improvements build momentum
Earnings Call Insights: CVRx, Inc. (CVRX) Q3 2025 MANAGEMENT VIEW * Kevin Hykes, President and CEO, stated that "Q3 was a strong quarter for CVRx. We grew revenue by double digits year-over-year a...
CVRx (CVRX) Reports Q3 Loss, Beats Revenue Estimates
CVRx (CVRX) came out with a quarterly loss of $0.49 per share versus the Zacks Consensus Estimate of a loss of $0.5. This compares to a loss of $0.57 per share a year ago. These figures are adjusted f...
CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuro...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
